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1. Introduction 
Our immune system constantly interacts with our internal environment, protects us from 
our external environment and provides the inherent knowledge to sense the difference 
between friend and foe with important implications in human health and disease (Pozo, 
2008). For these reasons, it is important to identify functional alteration of key immune 
responses as the number of silver nano-enabled products grows while the current data 
strongly suggest that other related nanomaterials, such as polymer nanoparticles, fullerenes, 
dendrimers and gold nanoparticles, interact with the immune system. 
 
In the present chapter, we will focus on the effects of engineered silver nanoparticles on the 
initiation and regulation of the immune response.  Particular attention will be paid on the 
potential clinical usefulness of silver nanoparticles in the context of its effects on the 
production of key immunological mediators, as well as its significance on bacterial and viral 
infections.  By a critical analysis of the current state of knowledge, the chapter will help to 
reduce the serious lack of information and controversial issues concerning the biological 
effects of silver nanoparticles on the immune system.  
 
2. The immune system 
Studies on the biological consequences of new nanomaterials suited for biomedical 
applications are of importance, particularly those related to the immune system. Therefore, 
the interactions of silver nanoparticles with the immune system and its potential effects and 
implications are key questions for nanomaterials that are intended for biomedical 
applications or extensive industrial manufacturing such as those considered in this chapter.  
For this reason, before explaining the variety of interactions, effects and implications, we 
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will start with a brief introduction about the functions of the immune system and its cellular 
components. 
The immune system is a dynamic network of cells, tissues, and organs that work 
coordinated to defend the body against attacks by "foreign" invaders and protects against 
disease by identifying "self" and "non-self" (for example virus, fungus, bacterium) cells and 
tissues (Christensen & Thomsen, 2009). 
To deal with antigens, the system uses specialized cells to recognize infiltrators and 
eliminate them. Detection is complicated as pathogens can evolve rapidly, producing 
adaptations that avoid the immune system and allow the pathogens to successfully infect 
their hosts (Christensen & Thomsen, 2009). For cellular communication there is a category of 
signaling molecules called cytokines. They are small secreted proteins which are critical to 
the development and functioning of both the innate and adaptive immune response, 
although they are not limited just to the immune system. They act by binding to specific 
membrane receptors, which produce cascades of intracellular signalling to alter cell 
functions. Cytokines have been classified as, lymphokines (cytokines made by 
lymphocytes), monokines (cytokines made by monocytes), chemokines (cytokines with 
chemotactic activities), and interleukins (cytokines made by one leukocyte to act on other 
leukocytes). The actions of cytokines may be grouped as, autocrine action (the cytokine acts 
on the cell that secretes it), paracrine action (the target is restricted to nearby cells), and 
endocrine action (the cytokine diffuses to distant regions of the body).  
 Fig. 1. The dynamic network of cells in the immune system. Recognition of pathogens leads 
the activation of T helper cells (Th). This process involves adaptive events that occur on the 
surface of the antigen presenting cells (APC). They display a foreign antigen complex with 
MHC on its surface recognized by T-cells using their T-cell receptor (TCR). The immune 
system contains three types of APC macrophages, dendritic cells and B cells. APC 
collaborate with the innate response by cytokine communication, which steer the 
differentiation of Th cells into Th1 or Th2 subsets. These T cells activate other cells of the 
immune system such as cytotoxic T cells (Tc), and macrophages (MФ). Silver nanoparticles 
can interact with the immune system and carry out different functions like binding and 
reacting with cells or proteins for drug delivery, detection, diagnosis and therapy (targeted 
and non-targeted). 
 
 
2.1 Adaptive immunity 
As part of this complex immune response, the human immune system adapts over time to 
recognize specific pathogens more efficiently. This adaptation process is referred to as 
adaptive immunity and creates immunological memory from a primary response to a 
specific pathogen, provides an enhanced response to secondary encounters with that same, 
specific pathogen.  
 
2.2 Innate immunity 
The innate immune system comprises the cells and mechanisms that defend the host from 
infection by other organisms, in a non-specific manner (Castellheim et al., 2009). This means 
that cells of the innate system recognize and respond to pathogens in a generic way, but 
unlike the adaptive immune system, does not confer long-lasting or protective immunity to 
the host. Innate immune systems provide immediate defense against infection (Rasmussen 
et al., 2009).  
 
3. Silver nanoparticles  
In nanotechnology, a nanoparticle is defined as a material with dimensions and tolerance 
limits of 0.1-100nm that behaves as a whole unit in terms of its transport, properties and 
unique characteristics. 
Metallic nanoparticles have unique optical, electrical and biological properties that have 
attracted significant attention due to their potential use in many applications, such as 
catalysis, biosensing, drug delivery and nanodevice fabrication. Capped silver nanoparticles 
(AgNPs) have many biomedical applications due to its excellent biocompatibility and 
antibacterial properties. It has been reported that silver nanoparticles interact with virus, 
bacteria, and the immune system, being the reason why in this chapter we will explain how 
the size, shape and composition of silver nanoparticles can have a significant effect on their 
efficacy and have to be kept in mind when using bioconjugates.  
 
3.1 Interaction of silver nanoparticles with key signaling pathways and soluble 
mediators 
Activation of the innate immune system is mediated by pattern recognition receptors (PRRs) 
on particular immunocompetent cells that recognize pathogen-associated molecular 
patterns. The best characterized signaling PRRs to date are the Toll-like receptors (TLRs) 
present in plants, invertebrates and vertebrates that represent a primitive host defense 
mechanism against bacteria, fungi and viruses. Toll-like receptors (TLRs) play an important 
role in innate immunity. Individual TLRs recognise microbial components that are 
conserved among pathogens, such recognition initiates necessary inflammatory immune 
responses and induces subsequent activation of adaptive immunity (Uematsu & Akira, 
2006). In conclusion TLRs are a type of pattern recognition receptors (PRRs) which recognize 
molecules broadly shared by pathogens but distinguishable from host molecules. TLRs can 
be divided into two groups according to their cellular localization: TLRs 1, 2, 4, 5 and 6 are 
mainly located on the cell surface and primarily recognize bacterial components, while TLRs 
3, 7, 8 and 9 are mostly found in the endocytic compartments and mainly recognize viral 
products (Akira et al., 2006).  
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Toll-like receptors (TLR) and their ligands are one of the main players in the initiation of 
innate immunity which precedes, and is required, for the establishment of adaptive 
immunity. Manipulating the immune response by using TLR agonists or antagonists might 
be of therapeutic and/or prophylactic value (Makkouk & Abdelnoor, 2009). Exogenous 
signals are provided by TLRs mechanisms which affect the initiation, maintenance and 
progression of inflammatory diseases. Moreover, reagents that enhance TLR signalling 
pathways can be powerful adjuvants for fighting pathogens or cancer. By contrast TLR 
antagonists or signalling inhibitors could block the activation of TLRs by neutralizing the 
ligands, blocking the receptors or preventing signalling, which can also have other beneficial 
therapeutic effects in autoimmune diseases and sepsis (Zuany-Amorim et al., 2002). 
This opens up new avenues in the world of adjuvants and illustrates the basic requirements 
for the design of NP conjugates that efficiently reach their target. 
It has recently been studied whether AgNPs with a narrow size distribution and protected 
with a monolayer of adsorbed tiopronin (Ag@tiopronin) had any functional impact on 
specific TLR stimulation of Interleukin-6 (IL-6) secretion in Raw 264.7 macrophages, a 
murine monocyte/macrophage cell line (Castillo et al., 2008),  and the effects of silver 
nanoparticles on cytokine expression by peripheral blood mononuclear cells (PBMC) (Shin 
et al., 2007), human mesenchymal stem cells (hMSCs) (Greulich et al., 2009), and J774 A1 
macrophages (Yen et al., 2009).  
 
 
Nanoparticles 
 
 
Cell type 
 
Concentration 
 
Size (nm) 
 
 
Cytokines 
 
Ref 
 
Ag@tiopronin 
 
Raw 264.7 
macrophages 
 
10 µg/mL 
 
~5  
 
IL-6 
 
Castillo et 
al (2008) 
 
AgNPs 
 
PBMC  
1, 3, 5, 10, 20 
µg/mL 
 
~1.5  
 
IL-5        
INF- γ      
TNF-α 
 
Shin et al 
(2007) 
 
                
AgNPs 
 
   J774 A1 
macrophages 
 
                
1 µg/mL 
 
Small: 2-4 
Medium: 5-7   
Large: 20-40   
 
IL-1        
IL-6        
TNF-α 
 
Greulich 
et al 
(2009) 
 
 
AgNPs 
hMSCs 0.05, 0.5, 1, 2.5, 
5, 50   µg/mL 
 
100 
IL-6        
IL-8        
IL-11 
 
Yen et al 
(2009) 
Table 1. The effect of silver nanoparticles on the production of cytokines. Silver NPs were 
found to strongly inhibit cytokine production by Raw 264.7 macrophages, PBMC, hMSCs 
and more weakly by J774 A1 macrophages. 
 
The results demonstrated that Ag@tiopronin do not show proinflammatory effects on 
macrophages and that interestingly, Ag@tiopronins differentially inhibits the IL-6 secretion 
 
mediated by specific TLRs located in the cell surface or in the endocytic compartments 
(Castillo et al., 2008).  
 
Moreover, the effects of silver nanoparticles on the production of cytokines by PBMC, 
hMSCs, were found to strongly inhibit cytokine production, for example, of INF- γ, IL-6, IL-
8, IL-11, TNF-α and more weakly IL-5. In the case of J774 A1 macrophages the expression 
levels of IL-1 and IL-6 were similar to controls. 
The biological effects of nanoparticles were analyzed by enzyme-linked immunosorbent 
assay (ELISA) in the case of PBMCs stimulated by phytohaemagglutinin (PHA) in the 
presence of NPs (Shin et al., 2007) and hMSCs stimulated previously by lipopolysaccaride 
(LPS) (Greulich et al., 2009). In the case of non-stimulated J774 A1 macrophages, the cytokine 
mRNA expression levels were analyzed in cells treated with NPs and were compared to the 
resting state, measured by RT-PCR (Yen et al., 2009).  
In contrast there are other nanoparticles such as SiO2 nanoparticles (Lucarelli et al., 2004), 
gold nanoparticles (AuNPs)(Yen et al., 2009), or very small size proteoliposomes  (VSSP) 
(Venier et al., 2007), that are dramatically pro-inflamatory.  
However, in these studies, nanoparticles had a very heterogeneous size (from 1.5 to 100 nm) 
and concentration (from 0.05 to 50 µg/mL) (see Table 1), so it is difficult to establish whether 
the effect is related to the chemical nature, the size or the concentration. In any case, in these 
different experiments, exposures to concentrations lower than 3 ppm did not produce a 
significant decrease of cytokine production. These effects can be considered for future 
medical applications, but we have to keep in mind the characteristics previously mentioned, 
as others like the easily uptake into cells or tissues and not so easy metabolism.  
 
3.2 Interaction of silver nanoparticles with virus 
The interaction of silver nanoparticles with viruses is a largely unexplored field. A virus is a 
sub-microscopic infectious agent that can only multiply in living cells of animals, plants, or 
bacteria. Viruses are about 1/100th the size of bacteria and consist of a single- or double-
stranded nucleic acid (DNA or RNA) surrounded by a protein shell called a capsid.  Some 
viruses have an outer envelope composed of lipids and proteins. The viral capsid proteins 
bind to the host cellular surface specific receptors. This attachment can induce the viral 
envelope protein to undergo changes that results in the fusion of viral and cellular 
membranes and may lead to an infection. For this reason there is a high interest studying 
possible mechanisms of binding NPs to the viral capsid and inhibit the later fusion. 
Recently, it has been suggested that nanoparticles bind with a viral envelope glycoprotein 
and inhibit the virus by binding to the disulfide bond regions 
of the CD4 binding domain within the gp120 glycoprotein, as demonstrated in vitro 
(Elechiguerra et al., 2005). Silver nanoparticles undergo a size-dependent interaction with 
HIV-1, nanoparticles ranging from 1 to 10 nm attached to the virus, and their surface 
chemistry can modify their interactions with viruses, tested with silver NPs that had three 
different surface chemistries: foamy carbon, poly (N-vinyl-2-pyrrolidone) (PVP), and bovine 
serum albumin (BSA).  Differences have been observed in HIV-1 inhibition and can be 
justified because BSA and PVP are directly bounded to the nanoparticle surface and are 
totally encapsulated, while the foamy carbon silver nanoparticles have fundamentally a free 
surface area, which exhibit higher inhibitory effect and cytotoxicity as they are able to have 
stronger interactions (Elechiguerra et al., 2005).  
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Within this unexplored area there are also other studies that analyse the interaction of silver 
nanoparticles with hepatitis B virus. The effects of silver NPs on hepatitis B virus (HBV) 
have been reported using an infection model HepAD38 human hepatoma cell line (Lu et al., 
2008). The binding affinity of NPs with different sizes (10 and 50 nm) for HBV DNA and 
extracellular virions resulted very high and could also inhibit the production of HBV RNA 
and extracellular virions in vitro, which was determined using a UV-vis absorption titration 
assay(Lu et al., 2008). It will need further investigation to find whether this binding activity 
prevents HBV virions from entering into host cells or not. In vivo studies with silver NPs are 
necessary to design therapeutics and vaccines that can specifically target viruses in order to 
increase therapeutic benefit and minimize adverse effects.  
 
3.3 Interaction of silver nanoparticles with bacteria 
Bacteria are prokaryotic, microscopic, single-celled organisms that lack membrane bound 
organelle in the cytoplasm. They can inhabit all kinds of environments and exist either as 
independent (free-living) organisms or as parasites. 
Silver has been used for at least six millennia in order to prevent microbial infections. It has 
been used to treat a wide variety of infections and has been effective against almost all 
organisms tested. Silver compounds were major weapons against wound infection in World 
War I until the advent of antibiotics and between 1900 and 1940, tens of thousands of 
patients consumed colloidal silver, and several million of doses were given intravenously. 
But it was shown that high doses of silver, when administered intravenously could cause 
convulsions or even death, and that oral administration of high doses could cause 
gastrointestinal disturbances (Alexander, 2009). For this reason the biomedical applications 
of silver can be effective by the use of biologically synthesized NPs, which minimize the 
factors such as toxicity and cost, and are found to be exceptionally stable and by virtue of 
extremely small size silver NPs exhibit unusual physicochemical properties and biological 
activities. Due to the large surface area (generally the diameter is smaller than 100nm and 
contains 20–15,000 silver atoms) for reaction of the NPs, the dose of silver used in medical 
applications can be reduced. 
The mechanisms of action and binding of silver nanoparticles to microbes remain unclear 
but it is known that silver binds to the bacterial cell wall and cell membrane and inhibits the 
respiration process (Klasen, 2000) by which the chemical energy of molecules is released and 
partially captured in the form of ATP. Silver nanoparticles interact with sulfur-containing 
proteins of the bacterial membrane as well as with the phosphorus containing compounds 
like DNA to inhibit replication (Silver et al., 2006). Bactericidal effect of silver has also been 
attributed to inactivation of the enzyme phosphomannose isomerase (Bhattacharya & 
Mukherjee, 2008), that catalyzes the conversion of mannose-6-phosphate to fructose-6-
phosphate which is an important intermediate of glycolysis, the most common pathway in 
bacteria for sugar catabolism. 
The antimicrobial activity of silver nanoparticles has been investigated against yeast, gram 
negative and positive bacteria (Kim et al., 2007) (Sondi & Salopek-Sondi, 2004; Yu, 2007).  
When silver nanoparticles were tested in yeast and Escherichia coli (Gram -), bacterial growth 
was inhibited (Sondi & Salopek-Sondi, 2004), but the inhibitory effect in Staphylococcus 
aureus (Gram +) was mild (Kim et al., 2007). Therefore, this suggests that the antimicrobial 
effects of silver nanoaparticles can be associated with different characteristics of the 
membrane structure, in order to the considerable differences between the membrane 
 
structures of Gram+ and Gram-. These differences mainly rely on the peptydoglycan layer 
thickness, the rigidity and extended cross linking that makes the penetration of 
nanoparticles very difficult.  
Recently, due to the emergence of antibiotic-resistant bacteria and the use limitations of 
antibiotics that can cause serious diseases and is an important public health problem 
(Furuya & Lowy, 2006), the synergetic effect of silver nanoparticles with antibiotics has been 
studied combinating silver nanoparticles with different antibiotics like ampicillin, 
kanamycin, erythromycin and chloramphenicol against gram positive and gram negative 
bacteria. The antibacterial activities of these antibiotics increase in the presence of silver 
nanoparticles against gram positive and gram negative bacteria determined by the disk 
diffusion method. Different diameters of inhibition zones have been shown around the 
different antibiotic disk with or without AgNPs. The combination effect of nanosilver and 
ampicillin has more potential compared to the other antibiotics and may be caused by both, 
the cell wall lysis action of the ampicillin and the DNA binding action of the silver 
nanoparticles (Fayaz et al., 2009). The antibiotic molecules contain many active groups such 
as hydroxyl and amido groups, which reacts easily with silver nanoparticles by chelation, 
for this reason, the synergistic effect may be caused by the bonding reaction with antibiotic 
and silver nanoparticles.  
The bactericidal effects of silver nanoparticles are part of an extensive research field due to 
its potential translation for biomedical applications such as, wound-healing (Tian et al., 2007; 
Silver et al., 2006), clothes, coating for medical devices (Roe et al., 2008), antimicrobial gel 
(Jain et al., 2009), and orthopaedic implants (Nair & Laurencin, 2008).  
It is well known that the use of central venous catheters is associated with bactericidal line 
infections, which is a usual problem (Stevens et al., 2009).  Contaminated or infected 
catheters are a major source of nosocomial infections responsible for > 40% of all episodes of 
nosocomial sepsis in acute-care hospitals (Samuel & Guggenbichler, 2004). For this reason 
catheters coated with silver NPs are important to confer antimicrobial activity and play an 
essential part in the prevention of catheter-related infections.  
In vivo studies have been performed to test the antimicrobial activity of catheters coated 
with silver NPs and it has been reported that the coating process is slowly reversible, 
yielding sustained release of silver for at least 10 days (Roe et al., 2008). Each animal 
(C57B1/6J male mice) was implanted with the equivalent of a 28 cm silver coated catheters 
and showed no sign of toxicity, inflammation or infection at the site of catheter 
implantation. The released silver is active against microorganisms with no risk of systemic 
toxicity and safety of use in animals. This suggests that catheters coated with this method 
could provide local protection against infections (Roe et al., 2008).  
However, some questions need to be addressed and more elaborate experimental evidences 
will be needed to clarify such as the exact mechanism of interaction of silver nanoparticles 
with the bacterial cells and the killing activity of the nanoparticle surface (Rai et al., 2009). 
 
3.4 Cytotoxicity, biodistribution and clearance. 
Biomedical applications of silver nanoparticles need to be cytocompatible and have the 
capacity to restore natural morphology of the tissue in contact without triggering 
immunogenecity. Therefore, the evaluations of these effects are of high importance for 
future medical purposes and prior to in vivo applications, in vitro methods are needed to 
evaluate cytocompatibility as a prerequisite. Silver nanoparticles studies work as basic tools 
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(C57B1/6J male mice) was implanted with the equivalent of a 28 cm silver coated catheters 
and showed no sign of toxicity, inflammation or infection at the site of catheter 
implantation. The released silver is active against microorganisms with no risk of systemic 
toxicity and safety of use in animals. This suggests that catheters coated with this method 
could provide local protection against infections (Roe et al., 2008).  
However, some questions need to be addressed and more elaborate experimental evidences 
will be needed to clarify such as the exact mechanism of interaction of silver nanoparticles 
with the bacterial cells and the killing activity of the nanoparticle surface (Rai et al., 2009). 
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Biomedical applications of silver nanoparticles need to be cytocompatible and have the 
capacity to restore natural morphology of the tissue in contact without triggering 
immunogenecity. Therefore, the evaluations of these effects are of high importance for 
future medical purposes and prior to in vivo applications, in vitro methods are needed to 
evaluate cytocompatibility as a prerequisite. Silver nanoparticles studies work as basic tools 
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for evaluating nanoparticle safety in order to foster the efficient movement of AgNPs 
products through preclinical and clinical development.  
Different assays are used to measure cell viability such as MTT assays, LDH assays and 
apoptosis/necrosis assays among others. MTT [3-(4,5-dimethylthiazoyl-2-yl)-2,5-
diphenyltetrazoliumbromide] assays, used to demonstrate the viability of cells through the 
reduction of the pale yellow MTT dye to a dark blue formazan product by the activity of 
succinate dehydrogenase present in the mithocondria of living cells, LDH (lactate 
dehydrogenase) assays, that consists in measuring the release of  this LDH stable 
cytoplasmic enzyme that is rapidly released into the cell-culture supernantant upon damage 
of the plasma membrane and apoptosis/necrosis assays detects changes in cell membrane 
permeability (Weyermann et al., 2005). 
 
As it has been reported, tiopronin silver nanoparticles (Castillo et al., 2008), BSA capped Ag-
Pt alloy nanoparticles (Singh et al., 2009) and silver nanoparticles protected with Na+-poly  
(γ -glutamic acid) (Yu, 2007) are not cytotoxic, while, by contrast bare silver nanoparticles  
have been found to be rather toxic (Braydich-Stolle et al., 2005; Kim et al., 2009; Hussain et al., 
2005). This supports the idea that the toxicity is associated to the presence of bare metallic 
nanoparticle surfaces, while particles protected by and organic layer are much less toxic 
except starch capped nanoparticles  which present mithocondrial dysfunction , induction of 
reactive oxygen species (ROS), DNA damage and cell cycle arrest (AshaRani et al., 2009). 
Serious limitations of these studies assessing biological properties of nanoparticles exist, 
such as the partial characterization of the material used and its size heterogeneity. This is 
one of the main causes of discrepancies in the literature (See Table 2). 
 
Nanoparticles Concentratio
n 
Size 
(nm) 
Cell type Toxicity signs Ref 
AgNPs 10 µg/mL 2-40 Murine 
macroph
ages 
 Spread shape Greulich et 
al (2009) 
 
Starch-
capped-NPs 
 
25-400 
µg/mL 
 
6-20 
 
IMR-90 
U251 
◦Mithocondrial 
damage 
◦ Increase of ROS 
◦ Reduced ATP 
content 
◦ DNA damage 
◦ Cell cycle arrest 
 
AshaRani 
et al (2009) 
 
AgNPs 
 
10 µg/mL 
 
15 
 
C18-4 
◦ Cell morphology 
changes 
◦ Reduced 
mithocondrial 
function            
◦Slight LDH 
leakage 
 
Braydich-
Stolle et al 
(2009) 
 
 
 
AgNPs 
               
0.1-10 
µg/mL 
 
5-10 
                    
HepG2 
◦ Reduced 
mithocondrial 
function            
◦LDH leakage   
◦Increase of ROS 
 
Kim et al 
(2009) 
 
AgNPs 
 
5-50 µg/mL 
 
15, 100 
 
BRL 3A 
◦Reduced 
mithocondrial 
function            
◦LDH leakage 
◦ Depletion of 
GSH level 
◦Increase of ROS 
 
Hussain et 
al (2005) 
BSA capped 
Ag-Pt alloy 
NPs 
               
50-100 µM 
          
10-15 
                    
HGF 
                   
None 
Singh et al 
(2009) 
 Ag@tiopronin        
 10 µg/mL 
          
~5 
Raw           
264.7    
macroph
ages 
                   
None 
Castillo et 
al (2008) 
Table 2. In vitro cytotoxicity studies of silver NPs on different cell lines. Toxicity signs seem 
to be associated to the presence of bare metallic nanoparticle surfaces, while particles 
protected by and organic layer seem to be much less toxic. 
 
Toxicity studies with silver NPs have been made in vivo using a zebrafish embryonic model, 
based on the putative similarity between the zebrafish and human genomes (Bar-Ilan et al., 
2009). All sizes of colloidal silver NPs caused toxicity in zebrafish embryos in a size-
dependent manner for certain concentrations and time points. Exposure to 250 μM (3, 10, 50 
and 100nm) of colloidal silver nanoparticles caused significantly different percentages of 
mortality, with 80%, 64%, 36%, and 3% respectively, by 24 hours post-fertilization; 250 μM 
of colloidal silver nanoparticles of all sizes caused almost 100% mortality by 120 hours post-
fertilization. Lethality caused by 100 μM is significantly lower than mortality caused by 250 
μM at almost all time points, although 100 μM of colloidal silver NPs causes low lethality 
that increases with time, the induced sublethal toxic effects are represented by high average 
toxicity values. Overall, there are other many different parameters that could be responsible 
for the adverse effects that induce nanoparticle toxicity, such as, concentration, stability, 
chemistry and/or functionalization (Bar-Ilan et al., 2009) 
The human body has several semi-open interfaces such as the respiratory tract, or 
gastrointestinal tract and skin for direct substance exchange with the environment and are 
also the principle routes of exposure to silver nanoparticles (Chen & Schluesener, 2008). At 
these sites, silver nanoparticles can carry out different functions like binding and reacting 
with proteins, deposition, clearance and translocation. If the administration comes from 
other portals, the nanoparticles will have a direct contact with blood components, with the 
cardiovascular system and are distributed throughout the body. For this reason, the need for 
comprehensive Absorption, Distribution, Metabolism and Excretion (ADME) studies for 
nanomaterials are crucial to provide examples of how physical properties affect the state of 
agglomeration or aggregation, surface characteristics and stability(Zolnik & Sadrieh, 2009). 
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Table 2. In vitro cytotoxicity studies of silver NPs on different cell lines. Toxicity signs seem 
to be associated to the presence of bare metallic nanoparticle surfaces, while particles 
protected by and organic layer seem to be much less toxic. 
 
Toxicity studies with silver NPs have been made in vivo using a zebrafish embryonic model, 
based on the putative similarity between the zebrafish and human genomes (Bar-Ilan et al., 
2009). All sizes of colloidal silver NPs caused toxicity in zebrafish embryos in a size-
dependent manner for certain concentrations and time points. Exposure to 250 μM (3, 10, 50 
and 100nm) of colloidal silver nanoparticles caused significantly different percentages of 
mortality, with 80%, 64%, 36%, and 3% respectively, by 24 hours post-fertilization; 250 μM 
of colloidal silver nanoparticles of all sizes caused almost 100% mortality by 120 hours post-
fertilization. Lethality caused by 100 μM is significantly lower than mortality caused by 250 
μM at almost all time points, although 100 μM of colloidal silver NPs causes low lethality 
that increases with time, the induced sublethal toxic effects are represented by high average 
toxicity values. Overall, there are other many different parameters that could be responsible 
for the adverse effects that induce nanoparticle toxicity, such as, concentration, stability, 
chemistry and/or functionalization (Bar-Ilan et al., 2009) 
The human body has several semi-open interfaces such as the respiratory tract, or 
gastrointestinal tract and skin for direct substance exchange with the environment and are 
also the principle routes of exposure to silver nanoparticles (Chen & Schluesener, 2008). At 
these sites, silver nanoparticles can carry out different functions like binding and reacting 
with proteins, deposition, clearance and translocation. If the administration comes from 
other portals, the nanoparticles will have a direct contact with blood components, with the 
cardiovascular system and are distributed throughout the body. For this reason, the need for 
comprehensive Absorption, Distribution, Metabolism and Excretion (ADME) studies for 
nanomaterials are crucial to provide examples of how physical properties affect the state of 
agglomeration or aggregation, surface characteristics and stability(Zolnik & Sadrieh, 2009). 
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However, the need for an open dialogue between industry, academia, research labs and 
regulatory agencies cannot be overemphasized and as such, active collaboration should be 
facilitated, so that safe and effective nanotechnology products are developed for clinical use 
to treat the complex diseases. 
 
4. Preclinical studies and clinical trials 
In terms of healing, the elucidation of pro-inflammatory and anti-inflammatoyry pathways 
is important for the development of strategies to defend regenerative tissue from damage 
caused by imbalances in cytokines, oxidants, antioxidants within the wound. Recently, 
information about specific subsets of inflammatory cell lineages and the cytokine network 
orchestrating inflammation associated with tissue repair has increased (Eming et al., 2007). 
It is known that silver NPs can promote wound healing and reduce scar appearance in a 
dose-dependent manner and that cytokines play an important role in these processes by 
their capacity to decrease wound inflammation and modulate fibrogenic cytokines (Tian et 
al., 2007; Wong et al., 2009). It has been shown in vivo that silver NPs act decreasing 
inflammation through cytokine modulation.  
Two animal models have been used for these experiments, twenty-week-old male BALB/C 
mice were used for all thermal injury experiments and C57BLKs/J-m +ldb, db/db 
(genetically diabetic) and C57BLKs/J-m (nondiabetic control) male mice were used for the 
impaired wound-healing animal model.  
For thermal injury the dorsum of each mouse was shaved from the base of the tail to the 
base of the neck, anesthetized and lade on a burn template. For the chronic wound model, 
the hair on the back of each mouse was shaved, and a piece of full-thickness skin was 
excised with scissors. The experiments were performed with spherical silver NPs (~14nm) at 
1mM. The expression patterns of IL-6, TGF-β1, IL-10, VEGF (vascular endothelial growth 
factor, a polypeptide that stimulates the growth of new blood vessels), and IFN-γ were 
investigated by real-time RT-PCR. Expression levels of IL-6 mRNA in the wound areas 
treated with silver NPs were maintained at statistically significant lower levels during the 
healing process while TGF-β1 levels were higher in the initial period of healing but 
decreased at a lower level during the later phase of healing. Furthermore, IL-10, VEGF and 
IFN-γ expression levels stayed higher in animals treated with silver NPs relative to the no-
treated ones. These results can confirm that silver NPs can modulate cytokine expression 
(Tian et al., 2007). 
At the time of injury, the production of pro-inflammatory cytokines and the expression of E-
selectin, chemokines and integrin ligands on endothelial cells mediate the selective 
recruitment of cutaneous lymphocyte-associated antigen positiveT-cells into the wound 
where they recognise the antigen for which their receptor is specific and become activated. 
The macrophages act as antigen presenting-cells and also express the co-stimulatory 
molecules that are essential for the T-cell activation. After antigen binding; T-cells 
differentiate into subtypes, preferentially into Th1 subsets and secrete interferon-gamma. 
Interferon-gamma is the major macrophage activating cytokine and enhances the effective 
functions of macrophages (Tsirogianni et al., 2006). The functional diversity of cytokines is 
thought to be important in dictating different phases of immunoinflammatory responses. 
Th1 cytokines are mostly involved in cell-mediated immunity associated with autoimmune 
disorders and allograft rejection, whereas Th2 cytokines are mostly involved in mediating 
 
allergic inflammation and chronic fibroproliferative disorders. The initial period of 4–5 
weeks of infection is largely driven by the Th1 cytokine. The Th1 response in the early phase 
of the infection is initiated by higher numbers of IFN-γ- secreting CD4 and CD8 cells in the 
spleen and lymph nodes (Azouz et al., 2004). For this reason to accomplish successful 
wound repair and tissue regeneration, the inflammatory response must be tightly regulated 
by silver NPs. The lack of amplification of the inflammatory cytokine cascade is important 
in providing a permissive environment for wound repair and tissue regeneration to 
proceed. These results have given an insight into the actions of silver and provided a novel 
therapeutic direction for wound treatment in clinical practice. Other experiments need to be 
focused on the effect of silver NPs on the lymphocyte subset of the Th1/Th2 profile and see 
how silver NPs affect their particular cytokine production.  
Moreover, other studies have been developed in vivo with a rat model of ulcerative colitis 
treated with nanocrystalline silver (40, 4 and 0.4 mg/kg) which demonstrated to have 
antimicrobial and anti-inflammatory properties (Bhol & Schechter, 2007). Ulcerative colitis is 
a form of inflamatory bowel disease which is a chronic inflammatory condition of the 
gastrointestinal tract. Ulcerative colitis is a disease of the large intestine or colon, which 
includes characteristic ulcers, or open sores.  Nanocrystalline silver (NP 32101) was 
administered intracolonically or orally and the study revealed that intracolonic treatment of 
NP 32101 at concentrations of 40 and 4 mg/kg significantly reduced colonic inflammation 
and that oral treatment with 40mg/kg also improved colonic lesions but was not effective at 
concentrations of 0.4 and 4 mg/kg. These results suggest that NP 32101 is much more 
effective when delivered locally to the target organ due to the increased potency with 
intracolonic treatment (Bhol & Schechter, 2007).  
 
Other experiments with nanocrystalline silver cream have been made using a murine model 
of allergic contact dermatitis. Dermatitis was induced on the ears of BALB/c mice using 
dinitrofluorobenzene and later treated with 1% of nanocrystalline cream, tacrolimus 
ointment (topical drug used for the treatment of eczema) or a high potency steroid, applied 
once a day for four days. The results showed significant reductions of ear swelling, 
erythema and histopathological inflammation with no significant difference between 
treatments. The effect of topical nanocrystalline silver on the induction of apoptosis of 
inflammatory cells and the role of nanocrystalline silver in suppresion of inflammatory 
cytokines was examined by measuring the mRNA expression and protein expression of IL-
12 and TNF-α. The expression of these inflammatory cytokines were significantly 
suppressed by nanocrystalline silver, tacrolimus and high potency steroid, but test sites 
treated with nanocrystalline silver showed more extensive apoptosis of inflammatory cells 
than the test sites treated with the other treatments (Bhol & Schechter, 2005) . 
 
Other in vivo studies will be needed for further assessment of the NPs in various fields such 
as medical devices, antimicrobial systems and drug delivery. 
 
At present clinical trials are being performed comparing central venous catheters with silver 
NPs versus conventional catheters. This study is currently recruiting participants. Catheters 
coated and/or impregnated with different antimicrobial agents have been proposed to 
reduce the risk of such infections. However, results obtained so far did not reach enough 
clinical relevance to consider these medicated catheters as a valid alternative to the 
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Other in vivo studies will be needed for further assessment of the NPs in various fields such 
as medical devices, antimicrobial systems and drug delivery. 
 
At present clinical trials are being performed comparing central venous catheters with silver 
NPs versus conventional catheters. This study is currently recruiting participants. Catheters 
coated and/or impregnated with different antimicrobial agents have been proposed to 
reduce the risk of such infections. However, results obtained so far did not reach enough 
clinical relevance to consider these medicated catheters as a valid alternative to the 
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conventional ones. (Data was obtained from Clinicaltrials.gov, a service of the U.S Natoinal 
Institutes of Health) 
Other clinical studies are being carried out about the efficacy of silver nanoparticle gel 
versus a common antibacterial hand gel. This study is also recruiting participants and the 
specific aims are to compare the immediate antimicrobial efficacy of a one-time application 
of silver nanoparticle gel, compare the persistent antimicrobial efficacy of a one-time 
application of silver nanoparticle gel (SilvaSorb®) versus an alcohol-based hand gel 
(Purell®) over a 10 minute time frame in producing a persistent reduction on transient 
bacterial counts isolated from hands seeded with S. marcescens and finally to Compare user 
acceptability of silver nanoparticle gel (SilvaSorb®) versus an alcohol-based hand gel 
(Purell®) using a self-assessment questionnaire. 
 
5. Future research 
The future research is now being shaping by a number of research groups that are actively 
trying to combine a variety of functions into so-called multifunctional silver nanoparticles.  
We can expect examples of applications that could include a metallic or semi-metallic core 
that responds to external energy field or which contains a delivered agent; targeting 
biomolecules for delivery to specific cellular or disease sites; an image contrast agent for 
tracking of movement and accumulation of the particles round the body.  Such 
multifunctional particles could also be tailored in size for delivery to different desired sites, 
tissues or cells. A major effort towards successful nanoparticle-based therapeutics will be to 
avoid extensive and non specific immunostimulatory or immunosuppressive reactions to 
the nanomaterials once administered into the body.  Also, these developments bring some 
degree of risk with it, and to bring a product to the clinic entails identifying all possible 
hazards, characterizing and quantifying the associated risks, including probabilities and 
severities, given current scientific knowledge, reducing risks to an acceptable level, 
balancing any remaining risk against benefit to the patient, and communicating effectively 
and appropriately on the nature of such remaining or “residual” risks.  This implies the 
future development of new or adapted methods appropriate to assess new medicinal 
products and devices involving silver nanoparticles.  Although many questions still require 
thorough investigation, the available data suggest that silver nanoparticles can be 
engineered to become part of the next generation of biocompatible drug delivery platforms.   
 
6. Glossary 
- MHC: The major histocompatibility complex is expressed on the surface of cells and 
displays self and non self antigens to T cells, primarily with the goal of eliminating foreign 
organisms and other invaders that can result in disease. 
- APC: The antigen-presenting cell or accessory cell displays foreign antigen complex with 
MHC on its surface. T-cells may recognize this complex using their T-cell receptor (TCR). 
- TLRs: Toll-like receptors recognize molecules that are broadly shared by pathogens but 
distinguishable from host molecules and activate immune cell responses.  
- ROS: Reactive oxygen species are molecules or ions that are highly reactive due to the 
incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include 
oxygen ions, superoxides, peroxides and free radicals. 
 
- Gram +: Gram-positive bacteria retain the violet stain used in Gram's method. This is 
characteristic of bacteria that have a cell wall composed of a thick layer of peptidologlycan. 
- Gram -: Gram-negative bacteria do not retain the violet stain (and take the color of the red 
counterstain) in Gram's method of staining. This is characteristic of bacteria that have a cell 
wall composed of a thin layer of peptydoglycan. 
- RT-PCR: a high sensitive technique used for the detection and quantification of DNA or 
messenger RNA (mRNA) in a sample. This technique consists of two parts, the synthesis of 
cDNA (complementary DNA), a reaction applied when the target sequence is RNA by 
reverse transcription (RT) and the amplification of a specific cDNA by the polymerase chain 
reaction (PCR).  
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Institutes of Health) 
Other clinical studies are being carried out about the efficacy of silver nanoparticle gel 
versus a common antibacterial hand gel. This study is also recruiting participants and the 
specific aims are to compare the immediate antimicrobial efficacy of a one-time application 
of silver nanoparticle gel, compare the persistent antimicrobial efficacy of a one-time 
application of silver nanoparticle gel (SilvaSorb®) versus an alcohol-based hand gel 
(Purell®) over a 10 minute time frame in producing a persistent reduction on transient 
bacterial counts isolated from hands seeded with S. marcescens and finally to Compare user 
acceptability of silver nanoparticle gel (SilvaSorb®) versus an alcohol-based hand gel 
(Purell®) using a self-assessment questionnaire. 
 
5. Future research 
The future research is now being shaping by a number of research groups that are actively 
trying to combine a variety of functions into so-called multifunctional silver nanoparticles.  
We can expect examples of applications that could include a metallic or semi-metallic core 
that responds to external energy field or which contains a delivered agent; targeting 
biomolecules for delivery to specific cellular or disease sites; an image contrast agent for 
tracking of movement and accumulation of the particles round the body.  Such 
multifunctional particles could also be tailored in size for delivery to different desired sites, 
tissues or cells. A major effort towards successful nanoparticle-based therapeutics will be to 
avoid extensive and non specific immunostimulatory or immunosuppressive reactions to 
the nanomaterials once administered into the body.  Also, these developments bring some 
degree of risk with it, and to bring a product to the clinic entails identifying all possible 
hazards, characterizing and quantifying the associated risks, including probabilities and 
severities, given current scientific knowledge, reducing risks to an acceptable level, 
balancing any remaining risk against benefit to the patient, and communicating effectively 
and appropriately on the nature of such remaining or “residual” risks.  This implies the 
future development of new or adapted methods appropriate to assess new medicinal 
products and devices involving silver nanoparticles.  Although many questions still require 
thorough investigation, the available data suggest that silver nanoparticles can be 
engineered to become part of the next generation of biocompatible drug delivery platforms.   
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MHC on its surface. T-cells may recognize this complex using their T-cell receptor (TCR). 
- TLRs: Toll-like receptors recognize molecules that are broadly shared by pathogens but 
distinguishable from host molecules and activate immune cell responses.  
- ROS: Reactive oxygen species are molecules or ions that are highly reactive due to the 
incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include 
oxygen ions, superoxides, peroxides and free radicals. 
 
- Gram +: Gram-positive bacteria retain the violet stain used in Gram's method. This is 
characteristic of bacteria that have a cell wall composed of a thick layer of peptidologlycan. 
- Gram -: Gram-negative bacteria do not retain the violet stain (and take the color of the red 
counterstain) in Gram's method of staining. This is characteristic of bacteria that have a cell 
wall composed of a thin layer of peptydoglycan. 
- RT-PCR: a high sensitive technique used for the detection and quantification of DNA or 
messenger RNA (mRNA) in a sample. This technique consists of two parts, the synthesis of 
cDNA (complementary DNA), a reaction applied when the target sequence is RNA by 
reverse transcription (RT) and the amplification of a specific cDNA by the polymerase chain 
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